Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. ((2-hexahydro-1(2h)-azocinyl)ethyl)guanidine
2. Guanethidine
3. Guanethidine Monosulfate
4. Guanethidine Sulfate (1:1)
5. Guanethidine Sulfate (1:2)
6. Guanethidine Sulfate (2:1)
7. Guanethidine Sulfate (2:1), 14c-labeled
8. Ismelin
9. Isobarin
10. Monosulfate, Guanethidine
11. Octadine
12. Oktadin
13. Sulfate, Guanethidine
1. 645-43-2
2. Guanethidine Monosulfate
3. Ismelin
4. Ismelin Sulfate
5. Guanethidine (sulfate)
6. Guanethidine Sulphae
7. 1-(2-(azocan-1-yl)ethyl)guanidine Sulfate
8. Guanethidine Monosulphate
9. 645-43-2 (sulfate)
10. 5uby8y002g
11. 2-[2-(azocan-1-yl)ethyl]guanidine;sulfuric Acid
12. Guanidine, (2-(hexahydro-1(2h)-azocinyl)ethyl)-, Sulfate (1:1)
13. Guanidine, [2-(hexahydro-1(2h)-azocinyl)ethyl]-, Sulfate (1:1)
14. Isobarin
15. Octadin
16. Octadine
17. Iporal
18. Guanetidin Sulfate
19. Guanethidinesulfate
20. 2-(octahydro-1-azocinyl)ethyl Guanidine Sulphate
21. Guanethidine Bisulfate
22. (2-(hexahydro-1(2h)-azocinyl)ethyl) Guanidine Hydrogen Sulfate
23. (2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine Sulfate (1:1)
24. Ismelin Sulfate (2:1)
25. Su 5864 Sulfate (1:1)
26. Chebi:51016
27. Nsc29863
28. Guanethidine Monosulfate [usan]
29. Einecs 211-442-0
30. Unii-5uby8y002g
31. Isomelin
32. Guanethidine Sulfate (1:1)
33. N-(2-guanidino Ethyl)heptamethylenimine Sulfate
34. Prestwick_249
35. Ismelin (tn)
36. [2-(hexahydro-1(2h)-azocinyl)ethyl]guanidine Sulfate (2:1)
37. Guanethidine Monosulfate [usan:usp]
38. Azocine, Sulfate (2:1)
39. Chembl1345
40. Schembl51039
41. Guanethidine Monosulphate Usp
42. Guanethidine Sulfate (jp17)
43. Spectrum1500323
44. Guanethidine Monosulfate (usp)
45. Schembl11658850
46. Hms501k21
47. (2-(hexahydro-(2h)-azocin-1-yl)ethyl)guanidinium Sulphate
48. Dtxsid20110019
49. Hms1568p16
50. Hms1920b19
51. Hms2091j05
52. Hms3749o19
53. Pharmakon1600-01500323
54. Methyltriallylammoniumbromide
55. Hy-b0800
56. Ac-479
57. Ccg-39688
58. Guanethidine Monosulfate [mi]
59. Mfcd00035403
60. Nsc757045
61. S5496
62. Akos015856688
63. Akos026750543
64. Wln: T8ntj A2myzum & 2wsqq
65. Cs-3931
66. Nsc-757045
67. Guanethidine Monosulfate [mart.]
68. Guanethidine Monosulfate [vandf]
69. Guanethidine Monosulfate [usp-rs]
70. Guanethidine Monosulfate [who-dd]
71. Ncgc00094691-01
72. Ncgc00094691-02
73. As-57397
74. .beta.-1-azacyclooctylethylguanidine Sulfate
75. Ft-0603504
76. Guanethidine Monosulfate [ep Impurity]
77. D04382
78. Esimil Component Guanethidine Monosulfate
79. Guanethidine Monosulfate [ep Monograph]
80. Guanethidine Monosulfate [usp Monograph]
81. [2-(octahydro-1-azocinyl)ethyl]guanidine Sulfate
82. Guanethidine Monosulfate Component Of Esimil
83. N-[2-(azocan-1-yl)ethyl]guanidine; Sulfuric Acid
84. Sr-05000001637
85. 1-[2-(azocan-1-yl)ethyl]guanidine (1/2h2so4)
86. Sr-05000001637-1
87. [2-(hexahydro-1(2h)-azocinyl)ethyl]guanidine Sulfate
88. N''-[2-(azocan-1-yl)ethyl]guanidine; Sulfuric Acid
89. Q27122277
90. N-[2-(hexahydro-1(2h)-azocinyl)ethyl]guanidine Sulfate
91. (2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine Sulfate (1:1).
92. (2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine Sulphate (1:1).
93. Guanidine, (2-(hexahydro-1(2h)-azocinyl)ethyl)-, Sulphate (1:1)
94. Guanethidine Monosulfate, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 296.39 g/mol |
|---|---|
| Molecular Formula | C10H24N4O4S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 296.15182643 g/mol |
| Monoisotopic Mass | 296.15182643 g/mol |
| Topological Polar Surface Area | 151 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 248 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Adrenergic Agents
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Guanethidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Guanethidine, including repackagers and relabelers. The FDA regulates Guanethidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Guanethidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Guanethidine supplier is an individual or a company that provides Guanethidine active pharmaceutical ingredient (API) or Guanethidine finished formulations upon request. The Guanethidine suppliers may include Guanethidine API manufacturers, exporters, distributors and traders.
click here to find a list of Guanethidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Guanethidine DMF (Drug Master File) is a document detailing the whole manufacturing process of Guanethidine active pharmaceutical ingredient (API) in detail. Different forms of Guanethidine DMFs exist exist since differing nations have different regulations, such as Guanethidine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Guanethidine DMF submitted to regulatory agencies in the US is known as a USDMF. Guanethidine USDMF includes data on Guanethidine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Guanethidine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Guanethidine suppliers with USDMF on PharmaCompass.
Guanethidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Guanethidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Guanethidine GMP manufacturer or Guanethidine GMP API supplier for your needs.
A Guanethidine CoA (Certificate of Analysis) is a formal document that attests to Guanethidine's compliance with Guanethidine specifications and serves as a tool for batch-level quality control.
Guanethidine CoA mostly includes findings from lab analyses of a specific batch. For each Guanethidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Guanethidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Guanethidine EP), Guanethidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Guanethidine USP).
LOOKING FOR A SUPPLIER?
